Virtus Investment Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History

Virtus Investment Advisers’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	11,705 -1,282	-10%	-$129K	0.32%	139
2026 Q1	$1.2M	Buy	12,987 +2,474	+24%	+$233K	0.33%	135
2025 Q4	$830K	Buy	10,513 +1,447	+16%	+$104K	0.23%	140
2025 Q3	$665K	Hold	9,066	–	–	0.19%	177
2025 Q2	$461K	Buy	9,066 +574	+7%	+$25.6K	0.16%	192
2025 Q1	$383K	Buy	+8,492	New	+$400K	0.1%	214
2023 Q4	–	Sell	-6,361	Closed	-$201K	–	374
2023 Q3	$201K	Buy	+6,361	New	+$174K	0.14%	177

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus Investment Advisers's MIRM Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Mirum Pharmaceuticals (MIRM) stake by 9.9% in Q2 2026, selling an estimated $129K and leaving 11,705 shares worth $1.37M. The position accounts for 0.32% of the portfolio, ranked #139.

Virtus Investment Advisers first reported a position in MIRM in Q3 2023 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Virtus Investment Advisers held 11,705 shares of Mirum Pharmaceuticals worth $1.37M as of Q2 2026.
Virtus Investment Advisers sold 1,282 Mirum Pharmaceuticals shares in Q2 2026, an estimated $129K.
Mirum Pharmaceuticals made up 0.32% of Virtus Investment Advisers's portfolio in Q2 2026, its #139 holding.
Virtus Investment Advisers first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.